2 indicted in connection with counterfeit Ozempic scheme in Florida
Summary
Two Indian men living in Dubai have been charged with smuggling and selling fake Ozempic, a popular weight-loss drug, in the United States. One man was brought to court after being extradited from Italy, while the other is still missing. They face multiple charges and could be sentenced to many years in prison if found guilty.Key Facts
- Swapnadip Roy (33) and Vicky Ramancha (37) were indicted in Florida in 2025 for smuggling counterfeit Ozempic into the U.S.
- Ozempic is a prescription drug made by Novo Nordisk, used for weight loss and diabetes.
- The counterfeit drugs came from unauthorized manufacturers in China and were sold at lower prices.
- The scheme ran from July 2023 to April 2024, involving thousands of fake units with fake packaging and needles.
- The FDA warned consumers in December 2023 about counterfeit Ozempic appearing in the U.S. supply chain.
- Roy was extradited from Italy and appeared in federal court; Ramancha is still at large.
- Charges include conspiracy, smuggling, and selling counterfeit drugs, with a possible sentence of up to 71 years in prison.
- Prosecutors say the men encouraged companies to ignore safety rules and threatened people involved in the scheme.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
